Divisadero Street Capital Management LP Acquires New Shares in Liquidia Corporation $LQDA

Divisadero Street Capital Management LP acquired a new position in shares of Liquidia Corporation (NASDAQ:LQDA) during the third quarter, Holdings Channel.com reports. The institutional investor acquired 158,004 shares of the company’s stock, valued at approximately $3,593,000.

A number of other institutional investors and hedge funds have also bought and sold shares of LQDA. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Liquidia by 4.7% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 37,681 shares of the company’s stock valued at $556,000 after purchasing an additional 1,700 shares during the last quarter. Goldman Sachs Group Inc. raised its position in Liquidia by 10.7% in the first quarter. Goldman Sachs Group Inc. now owns 861,231 shares of the company’s stock valued at $12,703,000 after purchasing an additional 82,955 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Liquidia by 15.2% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 121,756 shares of the company’s stock worth $1,796,000 after purchasing an additional 16,022 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of Liquidia by 2.4% during the second quarter. Geode Capital Management LLC now owns 1,405,747 shares of the company’s stock worth $17,517,000 after purchasing an additional 32,499 shares during the last quarter. Finally, Banco Bilbao Vizcaya Argentaria S.A. grew its holdings in shares of Liquidia by 466.7% during the second quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 170,000 shares of the company’s stock worth $2,192,000 after purchasing an additional 140,000 shares during the last quarter. Institutional investors and hedge funds own 64.54% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on LQDA. Needham & Company LLC raised their price objective on shares of Liquidia from $52.00 to $54.00 and gave the company a “buy” rating in a report on Thursday, March 5th. Zacks Research cut shares of Liquidia from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 27th. Jefferies Financial Group raised their price target on shares of Liquidia from $45.00 to $55.00 and gave the company a “buy” rating in a research note on Tuesday, January 13th. HC Wainwright lifted their price target on shares of Liquidia from $50.00 to $55.00 and gave the stock a “buy” rating in a report on Friday, March 6th. Finally, Oppenheimer increased their price objective on Liquidia from $16.00 to $19.00 and gave the company an “underperform” rating in a report on Thursday. Two analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, one has issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $42.67.

Liquidia Stock Down 2.4%

Liquidia stock opened at $36.66 on Monday. The firm has a market cap of $3.23 billion, a price-to-earnings ratio of -44.17 and a beta of 0.53. Liquidia Corporation has a 52-week low of $11.26 and a 52-week high of $46.67. The company has a debt-to-equity ratio of 2.97, a quick ratio of 1.84 and a current ratio of 2.01. The firm has a 50 day moving average price of $37.46 and a two-hundred day moving average price of $31.31.

Liquidia (NASDAQ:LQDA) last posted its quarterly earnings data on Thursday, March 5th. The company reported $0.15 EPS for the quarter, beating analysts’ consensus estimates of $0.08 by $0.07. Liquidia had a negative net margin of 43.53% and a negative return on equity of 209.33%. The company had revenue of $92.02 million for the quarter, compared to analyst estimates of $87.49 million. Liquidia’s quarterly revenue was up 3072.4% on a year-over-year basis. Equities analysts predict that Liquidia Corporation will post -1.51 EPS for the current year.

Insiders Place Their Bets

In other news, CFO Michael Kaseta sold 36,932 shares of Liquidia stock in a transaction dated Monday, January 12th. The stock was sold at an average price of $37.43, for a total value of $1,382,364.76. Following the completion of the transaction, the chief financial officer directly owned 350,919 shares of the company’s stock, valued at approximately $13,134,898.17. This trade represents a 9.52% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Scott Moomaw sold 20,533 shares of the business’s stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $37.43, for a total value of $768,550.19. Following the completion of the transaction, the insider directly owned 154,514 shares in the company, valued at $5,783,459.02. This represents a 11.73% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 212,534 shares of company stock valued at $7,964,719 over the last quarter. Company insiders own 30.10% of the company’s stock.

Liquidia Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).